This lecture will report on the malignancy risk in variuous immune dysregulation syndromes such as CTLA4 insufficiency, LRBA deficiency, and NFkB insufficiency. Case reports will illustrate the topic. Treatment options will be reviewed. A final quiz will test the knowledge of the audience.